Dr. Jeffrey Bednarski, M.D., Ph.D.
Claim this profileWashington University School of Medicine
Area of expertise
Acute Myeloid Leukemia
Jeffrey Bednarski, M.D., Ph.D. has run 3 trials for Acute Myeloid Leukemia. Some of their research focus areas include:
Severe Combined Immunodeficiency
Jeffrey Bednarski, M.D., Ph.D. has run 2 trials for Severe Combined Immunodeficiency. Some of their research focus areas include:
Affiliated Hospitals
Washington University School Of Medicine
Washington University
Clinical Trials Jeffrey Bednarski, M.D., Ph.D. is currently running
Memory-like NK Cells after Haploidentical Transplant
for AML
This trial represents a single institution phase I/II pilot study with the primary objective of establishing the safety and feasibility of generating and infusing ML NK cells after TCRαβ haplo-HCT.
Recruiting
1 award
Phase 1 & 2
12 criteria
Stem Cell Transplant
for Blood Cancer
This single arm pilot phase I study with safety run-in is designed to estimate the safety and efficacy of a familial mismatched or haploidentical hematopoietic stem cell transplantation (haplo-HSCT) using a novel graft modification technique (selective αβ-TCR and CD19 depletion).
Recruiting
1 award
Phase 1
More about Jeffrey Bednarski, M.D., Ph.D.
Clinical Trial Related
3 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Jeffrey Bednarski, M.D., Ph.D. has experience with
- Fludarabine
- Alemtuzumab
- Melphalan
- Thiotepa
- Busulfan
- Cell Processing For TCRαβ+/CD19+ Depletion
Breakdown of trials Jeffrey Bednarski, M.D., Ph.D. has run
Acute Myeloid Leukemia
Severe Combined Immunodeficiency
Childhood Leukemia
Chronic Granulomatous Disease
Deletion Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jeffrey Bednarski, M.D., Ph.D. specialize in?
Jeffrey Bednarski, M.D., Ph.D. focuses on Acute Myeloid Leukemia and Severe Combined Immunodeficiency. In particular, much of their work with Acute Myeloid Leukemia has involved Stage IV patients, or patients who are undergoing treatment.
Is Jeffrey Bednarski, M.D., Ph.D. currently recruiting for clinical trials?
Yes, Jeffrey Bednarski, M.D., Ph.D. is currently recruiting for 2 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Jeffrey Bednarski, M.D., Ph.D. has studied deeply?
Yes, Jeffrey Bednarski, M.D., Ph.D. has studied treatments such as Fludarabine, Alemtuzumab, Melphalan.
What is the best way to schedule an appointment with Jeffrey Bednarski, M.D., Ph.D.?
Apply for one of the trials that Jeffrey Bednarski, M.D., Ph.D. is conducting.
What is the office address of Jeffrey Bednarski, M.D., Ph.D.?
The office of Jeffrey Bednarski, M.D., Ph.D. is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.